Bisphenol S and female reproductive toxicity: a scoping review of human studies

review OA: closed public-domain-us
Full text JSON View on PubMed View at publisher
AI-generated deep summary by claude@2026-06, 2026-06-23 · read from full text

This scoping review examined human primary research on bisphenol S (BPS) exposure and female reproductive toxicity, including cohort, case-control, and cross-sectional studies that measured BPS in participants, reported original data, and adjusted for confounding. Across 34 included studies, limits of detection for BPS varied widely (0.002 to 0.20 ng/mL) and the proportion of detectable samples ranged from 14.8% to 100%, complicating comparison across studies. The review found BPS was associated with higher risk of polycystic ovarian syndrome in two studies and with gestational diabetes mellitus or related biomarkers in three studies, with additional associations reported for thyroid and other reproductive hormones and pubertal timing but in mixed directions. The paper does not explicitly discuss endometriosis or adenomyosis; it was included in the corpus via a keyword match in the upstream search index, and it reports that BPS was not associated with endometriosis.

Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works

Abstract

BACKGROUND: Bisphenol S (BPS) is a chemical analogue of Bisphenol A (BPA) used in the production of hard plastics, textiles, and thermal papers. As the use of BPA has declined, BPS human exposure has increased and is now widespread. BPS has endocrine-disrupting properties and growing evidence indicates BPS negatively impacts female reproductive health. OBJECTIVE: We conducted a scoping review of primary research articles related to BPS exposure and female reproductive toxicity in humans. METHODS: We searched five biomedical databases through January 2025 for studies that assessed the effects of BPS exposure on outcomes related to female reproduction in humans. Included studies used a cohort, case-control, or cross-sectional study design, measured BPS in individuals, presented original data analyses, and adjusted for confounding variables. We tabulated study characteristics and key findings of the included studies. RESULTS: The literature search and screening yielded thirty-four studies for inclusion. Across studies, the LOD for BPS varied widely, from 0.002 to 0.20 ng/mL, and so did the proportion of samples with detectable BPS, from 14.8% to 100%. BPS was associated with greater risk of polycystic ovarian syndrome in two studies and gestational diabetes mellitus or related biomarkers in three studies. BPS was also associated with changes in thyroid hormones, reproductive hormones, and pubertal timing, though the directions of effects for these outcomes were mixed. BPS was not associated with endometriosis, gestational hypertension, or infertility. SIGNIFICANCE: There is evidence from human studies that BPS exposure can cause some adverse female reproduction outcomes, though data were limited in number of studies per outcome, variable limits of BPS detection, and differences in exposure to BPS across samples. Despite limitations, epidemiologic data, considered along with in vitro and animal data, is important in identifying BPS as a hazard to female reproduction. IMPACT: Human exposure to BPS is increasing. The findings of this review of 34 epidemiologic studies suggests a link between BPS exposure and some adverse female reproductive health outcomes. This review also highlights data gaps in variable limits of BPS detection, differences in exposure, and the limited number of studies for specific outcomes. In addition to epidemiological evidence, in vitro and animal data show sufficient evidence to support BPS as a female reproductive.
Full text 24,583 characters · extracted from oa-doi-fallback · 6 sections · click to expand

Abstract

Background Bisphenol S (BPS) is a chemical analogue of Bisphenol A (BPA) used in the production of hard plastics, textiles, and thermal papers. As the use of BPA has declined, BPS human exposure has increased and is now widespread. BPS has endocrine-disrupting properties and growing evidence indicates BPS negatively impacts female reproductive health.

Objective

We conducted a scoping review of primary research articles related to BPS exposure and female reproductive toxicity in humans.

Methods

We searched five biomedical databases through January 2025 for studies that assessed the effects of BPS exposure on outcomes related to female reproduction in humans. Included studies used a cohort, case-control, or cross-sectional study design, measured BPS in individuals, presented original data analyses, and adjusted for confounding variables. We tabulated study characteristics and key findings of the included studies.

Results

The literature search and screening yielded thirty-four studies for inclusion. Across studies, the LOD for BPS varied widely, from 0.002 to 0.20 ng/mL, and so did the proportion of samples with detectable BPS, from 14.8% to 100%. BPS was associated with greater risk of polycystic ovarian syndrome in two studies and gestational diabetes mellitus or related biomarkers in three studies. BPS was also associated with changes in thyroid hormones, reproductive hormones, and pubertal timing, though the directions of effects for these outcomes were mixed. BPS was not associated with endometriosis, gestational hypertension, or infertility. Significance There is evidence from human studies that BPS exposure can cause some adverse female reproduction outcomes, though data were limited in number of studies per outcome, variable limits of BPS detection, and differences in exposure to BPS across samples. Despite limitations, epidemiologic data, considered along with in vitro and animal data, is important in identifying BPS as a hazard to female reproduction. Impact - Human exposure to BPS is increasing. The findings of this review of 34 epidemiologic studies suggests a link between BPS exposure and some adverse female reproductive health outcomes. This review also highlights data gaps in variable limits of BPS detection, differences in exposure, and the limited number of studies for specific outcomes. In addition to epidemiological evidence, in vitro and animal data show sufficient evidence to support BPS as a female reproductive This is a preview of subscription content, access via your institution Access options Subscribe to this journal Receive 6 print issues and online access 251,40 € per year only 41,90 € per issue Buy this article - Purchase on SpringerLink - Instant access to the full article PDF. 39,95 € Prices may be subject to local taxes which are calculated during checkout Similar content being viewed by others Data availability Data sharing not applicable to this article as no datasets were generated or analyzed during the current study. Notes Safe Drinking Water and Toxic Enforcement Act of 1986.

References

Ben-Jonathan N, Hugo ER. Bisphenols come in different flavors: Is “S” better than “A”? Endocrinology. 2016;157:1321–3. OEHHA. Evidence on the female reproductive toxicity of Bisphenol S. Reproductive and Cancer Hazard Assessment Branch. Office of Environmental Health Hazard Assessment. California Environmental Protection Agency. 2023. https://oehha.ca.gov/sites/default/files/media/downloads/crnr/bpsfemalehid100623.pdf. Kumar A, Gupta K, Tomer V, Kaur A, Kumar V. Bisphenols as human health hazard: A systematic review on potent sources, route of exposure, harmful effects and safe alternatives. Toxicol Int. 2018;25:78–92. Khmiri I, Côté J, Mantha M, Khemiri R, Lacroix M, Gely C, et al. Toxicokinetics of bisphenol-S and its glucuronide in plasma and urine following oral and dermal exposure in volunteers for the interpretation of biomonitoring data. Environ Int. 2020;138:105644. Oh J, Choi JW, Ahn YA, Kim S. Pharmacokinetics of bisphenol S in humans after single oral administration. Environ Int. 2018;112:127–33. US FDA. Bisphenol A (BPA): Use in Food Contact Application 2014 [updated 04/20/2023. Available from: https://www.fda.gov/food/food-additives-petitions/bisphenol-bpa-use-food-contact-application#regulations. ECHA (European Chemicals Agency). 4,4’-sulphonyldiphenol as a substance of very high concern because of its toxic for reproduction (article 57c), endocrine disrupting properties (article 57(f) - environment), endocrine disrupting properties (article 57(f) - human health) properties. 2022. Kim K, Shin HM, Busgang SA, Barr DB, Panuwet P, Schmidt RJ, et al. Temporal trends of phenol, paraben, and triclocarban exposure in California pregnant women during 2007-2014. Environ Sci Technol. 2021;55:11155–65. Gys C, Ait Bamai Y, Araki A, Bastiaensen M, Caballero-Casero N, Kishi R, et al. Biomonitoring and temporal trends of bisphenols exposure in Japanese school children. Environ Res. 2020;191:110172. Lehmler HJ, Liu B, Gadogbe M, Bao W. Exposure to bisphenol A, bisphenol F, and bisphenol S in U.S. Adults and Children: The National Health and Nutrition Examination Survey 2013-2014. ACS Omega. 2018;3:6523–32. Liao C, Liu F, Alomirah H, Loi VD, Mohd MA, Moon HB, et al. Bisphenol S in urine from the United States and seven Asian countries: occurrence and human exposures. Environ Sci Technol. 2012;46:6860–6. Rochester JR, Bolden AL. Bisphenol S and F: a systematic review and comparison of the hormonal activity of bisphenol A substitutes. Environ Health Perspect. 2015;123:643–50. Siracusa JS, Yin L, Measel E, Liang S, Yu X. Effects of bisphenol A and its analogs on reproductive health: a mini review. Reprod Toxicol. 2018;79:96–123. Al-Tannak NF, Novotny L. Bisphenol A and other related bisphenols as pervasive environmental toxicants affecting the human health mainly through endocrine disruption. Syst Rev Pharm. 2020;11:1162–70. den Braver-Sewradj SP, van Spronsen R, Hessel EVS. Substitution of bisphenol A: a review of the carcinogenicity, reproductive toxicity, and endocrine disruption potential of alternative substances. Crit Rev Toxicol. 2020;50:128–47. Qiu W, Zhan H, Hu J, Zhang T, Xu H, Wong M, et al. The occurrence, potential toxicity, and toxicity mechanism of bisphenol S, a substitute of bisphenol A: a critical review of recent progress. Ecotoxicol Environ Saf. 2019;173:192–202. Beausoleil C, Le Magueresse-Battistoni B, Viguié C, Babajko S, Canivenc-Lavier MC, Chevalier N, et al. Regulatory and academic studies to derive reference values for human health: the case of bisphenol S. Environ Res. 2022;204:112233. ECHA. (European Chemicals Agency). Substance name: 4,4’-sulphonyldiphenol, EC number: 201-250-5, CAS number: 80-09-1. Member State committee support document for identification of 4,4’-sulphonyldiphenol as a substance of very high concern because of its toxic for reproduction (article 57c), endocrine disrupting properties (article 57(f) - environment), endocrine disrupting properties (article 57(f) - human health) properties. 2022. Shapiro AJ, Antoni S, Guyton KZ, Lunn RM, Loomis D, Rusyn I, et al. Software tools to facilitate systematic review used for cancer hazard identification. Environ Health Perspect. 2018;126:104501. Segovia-Mendoza M, Palacios-Arreola MI, Monroy-Escamilla LM, Soto-Piña AE, Nava-Castro KE, Becerril-Alarcón Y, et al. Association of serum levels of plasticizers compounds, phthalates and bisphenols, in patients and survivors of breast cancer: a real connection? Int J Environ Res Public Health. 2022;19:8040. Šimková M, Vítků J, Kolátorová L, Vrbíková J, Vosátková M, Včelák J, et al. Endocrine disruptors, obesity, and cytokines - How relevant are they to PCOS? Physiol Res. 2020;69:279–93. Hu Y, Lai S, Li Y, Wu X, Xing M, Li X, et al. Association of urinary bisphenols with thyroid function in the general population: a cross-sectional study of an industrial park in China. Environ Sci Pollut Res Int. 2023;30:107517–32. Bigambo FM, Wang D, Sun J, Ding X, Li X, Gao B, et al. Association between urinary BPA substitutes and precocious puberty among girls: a single-exposure and mixed exposure approach from a Chinese case-control study. Toxics. 2023;11:905. Lu W, Sun Z, Wang Z, Qu M, Shi Z, Song Q, et al. The joint effects of bisphenols and iodine exposure on thyroid during pregnancy. Nutrients. 2023;15:3422. Soomro MH, England-Mason G, Liu J, Reardon AJF, MacDonald AM, Kinniburgh DW, et al. Associations between the chemical exposome and pregnancy induced hypertension. Environ Res. 2023;237:116838. Irvine N, Bell RC, Subhan FB, Field CJ, Liu J, MacDonald AM, et al. Maternal pre-pregnancy BMI influences the associations between bisphenol and phthalate exposures and maternal weight changes and fat accumulation. Environ Res. 2024;257:119276. Pu Y, Du Y, He J, He S, Chen Y, Cao A, et al. The mediating role of steroid hormones in the relationship between bisphenol A and its alternatives bisphenol S and F exposure and preeclampsia. J Steroid Biochem Mol Biol. 2024;244:106591. Ryva BA, Pacyga DC, Anderson KY, Calafat AM, Whalen J, Aung MT, et al. Associations of urinary non-persistent endocrine disrupting chemical biomarkers with early-to-mid pregnancy plasma sex-steroid and thyroid hormones. Environ Int. 2024;183:108433. Soomro MH, England-Mason G, Reardon AJF, Liu J, MacDonald AM, Kinniburgh DW, et al. Maternal exposure to bisphenols, phthalates, perfluoroalkyl acids, and trace elements and their associations with gestational diabetes mellitus in the APrON cohort. Reprod Toxicol. 2024;127:108612. Sturla Irizarry SM, Cathey AL, Rosario Pabon ZY, Velez Vega CM, Alshawabkeh AN, Cordero JF, et al. Urinary phenol and paraben concentrations in association with markers of inflammation during pregnancy in Puerto Rico. Sci Total Environ. 2024;921:170889. Zhang N, Zhao Y, Zhai L, Bai Y, Wei W, Sun Q, et al. Urinary concentrations of bisphenol A and its alternatives: Potential predictors of and associations with antral follicle count among women from an infertility clinic in Northern China. Environ Res. 2024;249:118433. Varshavsky JR, Meeker JD, Zimmerman E, Woodbury ML, Aung MT, Rosario-Pabon ZY, et al. Association of phenols, parabens, and their mixture with maternal blood pressure measurements in the PROTECT cohort. Environ Health Perspect. 2024;132:87004. Tang P, Liang J, Liao Q, Huang H, Guo X, Lin M, et al. Associations of bisphenol exposure with the risk of gestational diabetes mellitus: a nested case-control study in Guangxi, China. Environ Sci Pollut Res Int. 2021;30:25170–25180. Zhang W, Xia W, Liu W, Li X, Hu J, Zhang B, et al. Exposure to bisphenol a substitutes and gestational diabetes mellitus: a prospective cohort study in China. Front Endocrinol. 2019;10:262. Huang H, Liang J, Tang P, Yu C, Fan H, Liao Q, et al. Associations of bisphenol exposure with thyroid hormones in pregnant women: a prospective birth cohort study in China. Environ Sci Pollut Res Int. 2022;29:87170–83. Yue B, Ning S, Miao H, Fang C, Li J, Zhang L, et al. Human exposure to a mixture of endocrine disruptors and serum levels of thyroid hormones: a cross-sectional study. J Environ Sci. 2023;125:641–9. Wang Z, Miao M, Xu J, Chen Y, Liang H, Yang L, et al. Gestational exposure to bisphenol analogues and kisspeptin levels in pregnant women and their children: a pregnancy-birth cohort study. Sci Total Environ. 2022;848:157720. Zhan W, Tang W, Shen X, Xu H, Zhang J. Exposure to bisphenol A and its analogs and polycystic ovarian syndrome in women of childbearing age: a multicenter case-control study. Chemosphere. 2023;313:137463. Ao J, Huo X, Zhang J, Mao Y, Li G, Ye J, et al. Environmental exposure to bisphenol analogues and unexplained recurrent miscarriage: a case-control study. Environ Res. 2022;204:112293. Zhang N, Zhao Y, Zhai L, Bai Y, Jia L. Urinary bisphenol A and S are associated with diminished ovarian reserve in women from an infertility clinic in Northern China. Ecotoxicol Environ Saf. 2023;256:114867. Zhu Y, Hedderson MM, Calafat AM, Alexeeff SE, Feng J, Quesenberry CP, et al. Urinary phenols in early to midpregnancy and risk of gestational diabetes mellitus: a longitudinal study in a multiracial cohort. Diabetes. 2022;71:2539–51. Aker AM, Johns L, McElrath TF, Cantonwine DE, Mukherjee B, Meeker JD. Associations between maternal phenol and paraben urinary biomarkers and maternal hormones during pregnancy: a repeated measures study. Environ Int. 2018;113:341–9. Hu P, Pan C, Su W, Vinturache A, Hu Y, Dong X, et al. Associations between exposure to a mixture of phenols, parabens, and phthalates and sex steroid hormones in children 6-19 years from NHANES, 2013-2016. Sci Total Environ. 2022;822:153548. Wang Y, Aimuzi R, Nian M, Zhang Y, Luo K, Zhang J. Bisphenol A substitutes and sex hormones in children and adolescents. Chemosphere. 2021;278:130396. Zhan W, Yang H, Zhang J, Chen Q. Association between co-exposure to phenols and phthalates mixture and infertility risk in women. Environ Res. 2022;215:114244. Wesselink AK, Weuve J, Fruh V, Bethea TN, Claus Henn B, Harmon QE, et al. Urinary concentrations of phenols, parabens, and triclocarban in relation to uterine leiomyomata incidence and growth. Fertil Steril. 2021;116:1590–600. Aker AM, Ferguson KK, Rosario ZY, Mukherjee B, Alshawabkeh AN, Calafat AM, et al. A repeated measures study of phenol, paraben and Triclocarban urinary biomarkers and circulating maternal hormones during gestation in the Puerto Rico PROTECT cohort. Environ Health. 2019;18:28. Derakhshan A, Philips EM, Ghassabian A, Santos S, Asimakopoulos AG, Kannan K, et al. Association of urinary bisphenols during pregnancy with maternal, cord blood and childhood thyroid function. Environ Int. 2021;146:106160. Blaauwendraad SM, Jaddoe VW, Santos S, Kannan K, Dohle GR, Trasande L, et al. Associations of maternal urinary bisphenol and phthalate concentrations with offspring reproductive development. Environ Pollut. 2022;309:119745. Philips EM, Santos S, Steegers EAP, Asimakopoulos AG, Kannan K, Trasande L, et al. Maternal bisphenol and phthalate urine concentrations and weight gain during pregnancy. Environ Int. 2020;135:105342. Philips EM, Trasande L, Kahn LG, Gaillard R, Steegers EAP, Jaddoe VWV. Early pregnancy bisphenol and phthalate metabolite levels, maternal hemodynamics and gestational hypertensive disorders. Hum Reprod. 2019;34:365–73. Philips EM, Kahn LG, Jaddoe VWV, Shao Y, Asimakopoulos AG, Kannan K, et al. First trimester urinary bisphenol and phthalate concentrations and time to pregnancy: a population-based cohort analysis. J Clin Endocrinol Metab. 2018;103:3540–7. Derakhshan A, Shu H, Peeters RP, Kortenkamp A, Lindh CH, Demeneix B, et al. Association of urinary bisphenols and triclosan with thyroid function during early pregnancy. Environ Int. 2019;133:105123. Peinado FM, Lendínez I, Sotelo R, Iribarne-Durán LM, Fernández-Parra J, Vela-Soria F, et al. Association of urinary levels of bisphenols A, F, and S with endometriosis risk: preliminary results of the EndEA study. Int J Environ Res Public Health. 2020;17:1194. Jurewicz J, Majewska J, Berg A, Owczarek K, Zajdel R, Kaleta D, et al. Serum bisphenol A analogues in women diagnosed with the polycystic ovary syndrome - Is there an association? Environ Pollution. 2020;272:115962. Teeguarden JG, Calafat AM, Ye X, Doerge DR, Churchwell MI, Gunawan R, et al. Twenty-four hour human urine and serum profiles of bisphenol a during high-dietary exposure. Toxicol Sci J Soc Toxicol. 2011;123:48–57. Calafat AM, Koch HM, Swan SH, Hauser R, Goldman LR, Lanphear BP, et al. Misuse of blood serum to assess exposure to bisphenol A and phthalates. Breast Cancer Res BCR. 2013;15:403. Brown EDL, Obeng-Gyasi B, Hall JE, Shekhar S. The thyroid hormone axis and female reproduction. Int J Mol Sci. 2023;24:9815. Calsolaro V, Pasqualetti G, Niccolai F, Caraccio N, Monzani F. Thyroid disrupting chemicals. Int J Mol Sci. 2017;18:2583. Duntas LH. Chemical contamination and the thyroid. Endocrine. 2015;48:53–64. ACOG Practice Bulletin No. 190. Gestational diabetes mellitus. Obstet Gynecol. 2018;131:e49–64. American Diabetes A. 2. Classification and diagnosis of diabetes. standards of medical care in diabetes-2018. Diab Care. 2018;41:S13–27. Plows JF, Stanley JL, Baker PN, Reynolds CM, Vickers MH. The pathophysiology of gestational diabetes mellitus. Int J Mol Sci. 2018;19:3342. Mitra T, Gulati R, Ramachandran K, Rajiv R, Enninga EAL, Pierret CK, et al. Endocrine disrupting chemicals: gestational diabetes and beyond. Diabetol Metab Syndr. 2024;16:95. Naderi M, Wong MY, Gholami F. Developmental exposure of zebrafish (Danio rerio) to bisphenol-S impairs subsequent reproduction potential and hormonal balance in adults. Aquat Toxicol. 2014;148:195–203. Park CB, Kim GE, On J, Pyo H, Park JW, Cho SH. Sex-specific effects of bisphenol S with tissue-specific responsiveness in adult zebrafish: the antiandrogenic and antiestrogenic effects. Ecotoxiol Environ Saf. 2022;229:113102. Yanachkova V, Kamenov Z. The relationship between thyroid dysfunction during pregnancy and gestational diabetes mellitus. Endokrynol Pol. 2021;72:226–31. Yang S, Shi FT, Leung PC, Huang HF, Fan J. Low thyroid hormone in early pregnancy is associated with an increased risk of gestational diabetes mellitus. J Clin Endocrinol Metab. 2016;101:4237–43. Pinto S, Croce L, Carlier L, Cosson E, Rotondi M. Thyroid dysfunction during gestation and gestational diabetes mellitus: a complex relationship. J Endocrinol Investig. 2023;46:1737–59. Zhang C, Bai L, Sun K, Ding G, Liu X, Wu Y, et al. Association of maternal triglyceride responses to thyroid function in early pregnancy with gestational diabetes mellitus. Front Endocrinol. 2022;13:1032705. Kamai EM, McElrath TF, Ferguson KK. Fetal growth in environmental epidemiology: mechanisms, limitations, and a review of associations with biomarkers of non-persistent chemical exposures during pregnancy. Environ Health. 2019;18:43. American College of O, Gynecologists’ Committee on Practice B-G. ACOG practice bulletin no. 194: polycystic ovary syndrome. Obstet Gynecol. 2018;131:e157–71. Singh S, Pal N, Shubham S, Sarma DK, Verma V, Marotta F, et al. Polycystic ovary syndrome: etiology, current management, and future therapeutics. J Clin Med. 2023;12:1454. Ahsan N, Ullah H, Ullah W, Jahan S. Comparative effects of Bisphenol S and Bisphenol A on the development of female reproductive system in rats; a neonatal exposure study. Chemosphere. 2018;197:336–43. Ijaz S, Ullah A, Shaheen G, Jahan S. Exposure of BPA and its alternatives like BPB, BPF, and BPS impair subsequent reproductive potentials in adult female Sprague Dawley rats. Toxicol Mech Methods. 2020;30:60–72. Ji K, Hong S, Kho Y, Choi K. Effects of bisphenol S exposure on endocrine functions and reproduction of zebrafish. Environ Sci Technol. 2013;47:8793–800. Nourian A, Soleimanzadeh A, Shalizar Jalali A, Najafi G. Bisphenol-A analogue (bisphenol-S) exposure alters female reproductive tract and apoptosis/oxidative gene expression in blastocyst-derived cells. Iran J Basic Med Sci. 2020;23:576–85. Pal S, Sahu A, Verma R, Haldar C. BPS-induced ovarian dysfunction: protective actions of melatonin via modulation of SIRT-1/Nrf2/NFĸB and IR/PI3K/pAkt/GLUT-4 expressions in adult golden hamster. J Pineal Res. 2023;75:e12869. Aker A, McConnell RER, Loch-Caruso R, Park SK, Mukherjee B, Rosario ZY, et al. Interactions between chemicals and non-chemical stressors: the modifying effect of life events on the association between triclocarban, phenols and parabens with gestational length in a Puerto Rican cohort. Sci Total Environ. 2020;708:134719. Hu J, Zhao H, Braun JM, Zheng T, Zhang B, Xia W, et al. Associations of trimester-specific exposure to bisphenols with size at birth: a Chinese prenatal cohort study. Environ Health Perspect. 2019;127:107001. Huang S, Li J, Xu S, Zhao H, Li Y, Zhou Y, et al. Bisphenol A and bisphenol S exposures during pregnancy and gestational age - a longitudinal study in China. Chemosphere. 2019;237:124426. Stevens DR, Starling AP, Bommarito PA, Keil AP, Nakiwala D, Calafat AM, et al. Midpregnancy phthalate and phenol biomarkers in relation to infant body composition: The Healthy Start Prospective Cohort. Environ Health Perspect. 2023;131:87017. Wang J, Mei H, Zhou AF, Huang LL, Cao ZQ, Hong AB, et al. The associations of birth outcome differences in twins with prenatal exposure to bisphenol A and its alternatives. Environ Res. 2021;200:111459. Zhang Y, Mustieles V, Williams PL, Yland J, Souter I, Braun JM, et al. Prenatal urinary concentrations of phenols and risk of preterm birth: exploring windows of vulnerability. Fertil Steril. 2021;116:820–32. Jiang Y, Li J, Xu S, Zhou Y, Zhao H, Li Y, et al. Prenatal exposure to bisphenol A and its alternatives and child neurodevelopment at 2 years. J Hazard Mater. 2020;388:121774. Xiong C, Xu L, Dong X, Cao Z, Wang Y, Chen K, et al. Trimester-specific associations of maternal exposure to bisphenols with neonatal thyroid stimulating hormone levels: a birth cohort study. Sci Total Environ. 2023;880:163354. van Zwol-Janssens C, Trasande L, Asimakopoulos AG, Martinez-Moral MP, Kannan K, Philips EM, et al. Fetal exposure to bisphenols and phthalates and childhood bone mass: a population-based prospective cohort study. Environ Res. 2020;186:109602. Hansel MC, Rosenberg AM, Kinkade CW, Capurro C, Rivera-Nunez Z, Barrett ES. Exposure to synthetic endocrine-disrupting chemicals in relation to maternal and fetal sex steroid hormones: a scoping review. Curr Environ Health Rep. 2024;11:356–79. Orsini N, Li R, Wolk A, Khudyakov P, Spiegelman D. Meta-analysis for linear and nonlinear dose-response relations: examples, an evaluation of approximations, and software. Am J Epidemiol. 2012;175:66–73. Trasande L, Nelson ME, Alshawabkeh A, Barrett ES, Buckley JP, Dabelea D, et al. Prenatal phenol and paraben exposures and adverse birth outcomes: a prospective analysis of US births. Environ Int. 2023;183:108378. OEHHA. Developmental and Reproductive Toxicant Identification (DARTIC) Members. 2023. https://oehha.ca.gov/proposition-65/developmental-and-reproductive-toxicant-identification-committee-darticmembers. OEHHA. Developmental and Reproductive Toxicant Identification Committee Meeting Transcript. California Environmental Protection Agency. Sacramento, California. 2023. https://oehha.ca.gov/sites/default/files/media/downloads/crnr/23-12-12-oehhadartic508.pdf.

Acknowledgements

We would like to acknowledge Nancy Firchow, MLS for conducting the primary literature search. We would also like to acknowledge OEHHA staff members, Farla Kaufman, Ph.D., Poorni Iyer, DVM, Ph.D., DABT and Yassaman Niknam, Ph.D. for their help reviewing and interpreting data related to BPS and female reproductive toxicity, and Aalekhya Reddam, Ph.D. and Ruwan Thilakaratne, Ph.D. for their critical internal review of the manuscript. Funding No financial assistance was received in support of the study. Author information Authors and Affiliations Contributions MS: Conceptualization, data interpretation, writing (review & editing); FM: Conceptualization, data interpretation, writing (review & editing); FA: Literature screening, data extraction, data interpretation, writing (original draft); JP: Data extraction, data interpretation, writing (original draft); ED: Literature screening, data extraction, data interpretation, writing (original draft); All authors reviewed the results and approved the final version of the manuscript. Corresponding authors Ethics declarations Competing interests The authors declare no competing interests. Additional information Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations. Supplementary information Rights and permissions Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law. About this article Cite this article Andrews, F.V., Delker, E., Paul, J. et al. Bisphenol S and female reproductive toxicity: a scoping review of human studies. J Expo Sci Environ Epidemiol (2026). https://doi.org/10.1038/s41370-026-00868-5 Received: Revised: Accepted: Published: Version of record: DOI: https://doi.org/10.1038/s41370-026-00868-5

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

Ask this paper AI returns verbatim quotes from the full text · source: oa-doi-fallback

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Condition tags

endometriosisinfertility

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. This is a recent paper (2026) — citers typically take a year or two to land, and the OpenAlex reference graph may still be filling in.

Source provenance

europepmc
last seen: 2026-06-23T06:15:44.889181+00:00
pubmed
last seen: 2026-06-23T06:11:18.963648+00:00
unpaywall
last seen: 2026-05-11T08:34:28.763810+00:00
License: public-domain-us · commercial use OK · attribution required
Courtesy of the U.S. National Library of Medicine